bgb-30813
Showing 1 - 1 of 1
Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)
Not yet recruiting
- Advanced Solid Tumors
- BGB-30813
- Tislelizumab
-
Hackensack, New Jersey
- +10 more
Jun 6, 2023